Longpre Lara
- SEC CIK
- 0001780347
No open-market purchases or sales filed in the past year.
Current role at each company
- MIRM Mirum Pharmaceuticals, Inc.CHIEF DEVELOPMENT OFFICERas of Mar 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Longpre Lara as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 (view filing) | Sep 10, 2019 | 1,651 daysLate | Longpre LaraCHIEF DEVELOPMENT OFFICER | PPurchase | +965 | $10.64 | +$10.3K | +0.9%105.4K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −1.00K | $20.62 | −$20.7K | −1.0%104.4K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −847 | $26.19 | −$22.2K | −0.8%104.4K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −1.02K | $28.04 | −$28.6K | −1.0%105.3K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Longpre LaraChief Development Officer | SSale | −1.00K | $25.65 | −$25.8K | −0.9%105.8K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Longpre LaraChief Development Officer | SSale | −961 | $19.26 | −$18.5K | −1.1%84.2K after |